Lakeshore Biopharma (LSB) Stock Chart & Stock Price History $1.10 -0.05 (-4.35%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.10 0.00 (0.00%) As of 05/21/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lakeshore Biopharma Stock Price Performance The Lakeshore Biopharma (LSB) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 68.21%. In the past month, the stock has decreased 18.82%, reflecting recent market activity. As of the latest close, Lakeshore Biopharma traded at $1.10 with a market cap of $10.24 million and volume of 5,093 shares. Receive LSB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lakeshore Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.51%1 Month Performance-18.82%3 Month Performance-51.00%Year-To-Date Performance-68.21% LSB Stock Chart for Thursday, May, 22, 2025 LSB Chart by TradingView Lakeshore Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/21/2025$1.15$1.10-4.35%$1.16$1.105,093 shs$10.24 million05/20/2025$1.13$1.15+1.77%$1.22$1.0911,959 shs$10.70 million05/19/2025$1.14$1.13-0.88%$1.13$1.092,439 shs$10.52 million05/16/2025$1.08$1.14+5.84%$1.23$1.014,776 shs$10.61 million05/15/2025$1.15$1.08-6.16%$1.21$1.0527,236 shs$10.02 million05/14/2025$1.16$1.15-1.06%$1.19$1.137,991 shs$10.68 million05/13/2025$1.16$1.16+0.01%$1.22$1.1646,353 shs$10.80 million05/12/2025$1.14$1.16+1.75%$1.23$1.1443,938 shs$10.80 million05/09/2025$1.17$1.14-2.56%$1.20$1.147,056 shs$10.61 million05/08/2025$1.16$1.17+0.86%$1.20$1.164,838 shs$10.89 million Get the Latest News and Ratings for LSB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lakeshore Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/07/2025$1.20$1.16-2.93%$1.28$1.1624,856 shs$10.80 million05/06/2025$1.19$1.20+0.42%$1.22$1.174,238 shs$11.12 million05/05/2025$1.19$1.19$1.24$1.1813,318 shs$11.07 million05/02/2025$1.23$1.19-3.25%$1.26$1.1713,621 shs$11.07 million05/01/2025$1.20$1.23+2.50%$1.25$1.164,325 shs$11.45 million04/30/2025$1.20$1.20+0.38%$1.21$1.1711,792 shs$11.17 million04/29/2025$1.24$1.20-3.59%$1.22$1.1816,102 shs$11.13 million04/28/2025$1.22$1.24+1.64%$1.27$1.1518,080 shs$11.54 million04/25/2025$1.33$1.22-8.27%$1.37$1.2216,636 shs$11.35 million04/24/2025$1.33$1.33$1.40$1.2538,144 shs$12.38 million04/23/2025$1.36$1.33-1.85%$1.49$1.333,701 shs$12.38 million04/22/2025$1.28$1.36+5.86%$1.40$1.305,776 shs$12.61 million04/21/2025$1.32$1.28-2.96%$1.44$1.2614,562 shs$11.91 million Related Companies Acrivon Therapeutics Stock Chart Iterum Therapeutics Stock Chart Spero Therapeutics Stock Chart Eliem Therapeutics Stock Chart Pluri Stock Chart Alterity Therapeutics Stock Chart Aligos Therapeutics Stock Chart Lantern Pharma Stock Chart Barinthus Biotherapeutics Stock Chart Mana Capital Acquisition Stock Chart Receive LSB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lakeshore Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LSB) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lakeshore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lakeshore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
